Induction of MHC class I expression by the MHC class II transactivator CIITA

被引:187
作者
Martin, BK
Chin, KC
Olsen, JC
Skinner, CA
Dey, A
Ozato, K
Ting, JPY
机构
[1] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT MED,CHAPEL HILL,NC 27599
[4] NICHHD,LAB MOL GROWTH REGULAT,NIH,BETHESDA,MD 20892
关键词
D O I
10.1016/S1074-7613(00)80347-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class I-deficient cell lines were used to demonstrate that the MHC class II transactivator (CIITA) can induce surface expression of MHC class I molecules. CIITA induces the promoter of MHC class I heavy chain genes. The site alpha DNA element is the target for CIITA-induced transactivation of class I. In addition, interferon-gamma (IFN gamma)-induced MHC class I expression also requires an intact site alpha. The G3A cell line, which is defective in CIITA induction, does not induce MHC class I antigen and promoter in response to IFN gamma. Trans-dominant-negative forms of CIITA reduce class I MHC promoter function and surface antigen expression. Collectively, these data argue that CIITA has a role in class I MHC gene induction.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 54 条
[1]  
AUSEBEL FM, 1987, CURRENT PROTOCOLS MO
[2]  
Burke P A, 1989, Year Immunol, V4, P23
[3]   CLASS-II TRANSACTIVATOR REGULATES THE EXPRESSION OF MULTIPLE GENES INVOLVED IN ANTIGEN PRESENTATION [J].
CHANG, CH ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :765-767
[4]   CLASS-II TRANSACTIVATOR (CIITA) IS SUFFICIENT FOR THE INDUCIBLE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES [J].
CHANG, CH ;
FONTES, JD ;
PETERLIN, M ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1367-1374
[5]   Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression [J].
Chang, CH ;
Guerder, S ;
Hong, SC ;
vanEwijk, W ;
Flavell, RA .
IMMUNITY, 1996, 4 (02) :167-178
[6]   TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J].
CHEN, LP ;
MCGOWAN, P ;
ASHE, S ;
JOHNSTON, J ;
LI, YW ;
HELLSTROM, I ;
HELLSTROM, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :523-532
[7]   MOLECULAR ANALYSIS OF G1B AND G3A IFN-GAMMA MUTANTS REVEALS THAT DEFECTS IN CIITA OR RFX RESULT IN DEFECTIVE CLASS-II MHC AND II-GENE INDUCTION [J].
CHIN, KC ;
MAO, C ;
SKINNER, C ;
RILEY, JL ;
WRIGHT, KL ;
MORENO, CS ;
STARK, GR ;
BOSS, JM ;
TING, JPY .
IMMUNITY, 1994, 1 (08) :687-697
[8]   Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants [J].
Chin, KC ;
Li, GGX ;
Ting, JPY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2501-2506
[9]  
CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259
[10]   DIFFERENCES IN MHC AND TAP-1 EXPRESSION IN CERVICAL-CANCER LYMPH-NODE METASTASES AS COMPARED WITH THE PRIMARY TUMORS [J].
CROMME, FV ;
VANBOMMEL, PFJ ;
WALBOOMERS, JMM ;
GALLEE, MPW ;
STERN, PL ;
KENEMANS, P ;
HELMERHORST, TJM ;
STUKART, MJ ;
MEIJER, CJLM .
BRITISH JOURNAL OF CANCER, 1994, 69 (06) :1176-1181